(19)
(11) EP 1 320 533 A1

(12)

(43) Date of publication:
25.06.2003 Bulletin 2003/26

(21) Application number: 01918879.6

(22) Date of filing: 20.03.2001
(51) International Patent Classification (IPC)7: C07D 501/59, A61K 31/546, A61P 31/04
(86) International application number:
PCT/US0108/980
(87) International publication number:
WO 0202/4708 (28.03.2002 Gazette 2002/12)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.09.2000 US 668722

(71) Applicants:
  • Essential Therapeutics, Inc.
    Mountainview, CA 94043 (US)
  • Hecker, Scott J.
    Los Gatos, CA 95032 (US)
  • Cho, Aesop
    Mountain View, CA 94040 (US)
  • Glinka, Tomasz W.
    Sunnyvale, CA 94086 (US)
  • Calkins, Trevor
    Londonderry, NH 03053 (US)
  • Lee, Ving J.
    Los Altos, CA 94024 (US)

(72) Inventors:
  • HECKER, Scott, J.
    Los Gatos, CA 95032 (US)
  • CHO, Aesop
    Mountain View, CA 94040 (US)
  • GLINKA, Tomasz, W.
    Sunnyvale, CA 94086 (US)
  • CALKINS, Trevor
    Londonderry, NH 03053 (US)
  • LEE, Ving, J.
    Los Altos, CA 94024 (US)

(74) Representative: Kirschner, Klaus Dieter, Dipl.-Phys. et al
Schneiders & BehrendtRechtsanwälte - PatentanwälteSollner Strasse 38
81479 München
81479 München (DE)

   


(54) PRODRUGS OF A 7-ACYLAMINO-3-HETEROARYLTHIO-3-CEPHEM CARBOXYLIC ACID ANTIBIOTIC